In a patient with a history of severe cirrhosis or liver cancer, which contraceptive method would be preferred?

In a patient with a history of severe cirrhosis or liver cancer, which contraceptive method would be preferred?

• A. Copper T 380A intrauterine device (ParaGard)
• B. Levonorgestrel-releasing intrauterine device (Mirena)
• C. Combined oral contraceptive pill
• D. Condoms

Answer: (C)

In significant liver disease, estrogen-containing contraception is avoided because estrogen can worsen liver pathology and increase risks such as cholestasis or hepatic adenomas. The safest, most reliable option that won’t affect the liver is a nonhormonal, long-acting method—the copper intrauterine device. It provides highly effective contraception without systemic hormones or hepatic metabolism. Alternatives like the combined oral contraceptive pill carry estrogen and are not preferred here due to liver disease. The levonorgestrel-releasing IUD is hormonal, which carries some systemic exposure, and condoms, while useful, are less effective overall with typical use. So the copper IUD is the best choice in this scenario.

In significant liver disease, estrogen-containing contraception is avoided because estrogen can worsen liver pathology and increase risks such as cholestasis or hepatic adenomas. The safest, most reliable option that won’t affect the liver is a nonhormonal, long-acting method—the copper intrauterine device. It provides highly effective contraception without systemic hormones or hepatic metabolism.

Alternatives like the combined oral contraceptive pill carry estrogen and are not preferred here due to liver disease. The levonorgestrel-releasing IUD is hormonal, which carries some systemic exposure, and condoms, while useful, are less effective overall with typical use. So the copper IUD is the best choice in this scenario.